Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study

Duranti, ; S, ; Inno, ; A, ; Rossi, ; V, ; Turazza, M; Fiorio, ; E, ; Fabi, ; A, ; Bisagni, ; G, ; Foglietta, ; J, ; Santini, ; D, ; Pavese, ; I, ; Zambelli, A; Vic, P; Leonardi, ; V, ; Barni, S; Barni, S; Saracchini, S; Bogina, G Lunardi G; Marchetti, F; Montemurro, F; Gori, ; S,